The relationship between salivary histatin levels and oral yeast carriage

Oral Microbiology and Immunology

Volumn 13, Issue 3, 1998, Pages 181-187

  Jainkittivong, A ^a,c   Johnson, D A ^a   Yeh, C K ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Candida; Histatins; Saliva; Yeast

Indexed keywords

EID: 0032101863     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.1998.tb00730.x     Document Type: Article

References (32)

1. Arendorf TM, Walker DM. Oral candidal populations in health and disease. Br Dent J 1979: 147: 267-272.
2. Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980: 25: 1-10.
3. Arneberg P. Quantitative determination of protein in saliva. Scand J Dent Res 1971: 79: 60-64.
4. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquit Immune Defic Syndr 1990: 3: 41-48.
5. Baum BJ, Bird JL, Longton RW. Polyacrylamide gel electrophoresis of human salivary histidine-rich polypeptides. J Dent Res 1977: 56: 1115-1118.
6. Dabbagh WK, Xu T, Oppenheim FG. Densitometric determination of histatin concentrations in saliva. J Dent Res 1993: 72: 322 (abstr).
7. Dabbagh WK, Xu T, Oppenheim FG. Immunological and densitometric determination of histatin concentration in saliva. J Dent Res 1994: 73: 150 (abstr).
8. Dodds MWJ, Johnson DA, Mobley CC, Hattaway KM. Parotid saliva protein profiles in caries-free and caries-active adults. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 83: 244-251.
9. Driscoll, J Duan C, Zuo Y, Xu T, Troxler R, Oppenheim FG. Candidacidal activity of human salivary histatin recombinant variants produces by site-directed mutagenesis. Gene 1996: 177: 29-34
10. Jensen JL, Xu T, Lamkin MS, Broden P, Aars H, Berg T, Oppenheim FG. Physiological regulation of the secretion of histatins and statherins in human parotid saliva J Dent Res 1994: 73: 1811-1817.
11. Kinateder LJ, Johnson DA, Dodds MWJ. Changes in salivary histatin concentrations with flow rate. J Dent Res 1994: 73: 192 (abstr)
12. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984: 311: 354-358.
13. Lal K, Pollock JJ, Santarpia RP III et al. Pilot study comparing the salivary cationic protein concentrations in health adults and AIDS patients: Correlation with antifungal activity. J Acquir Immune Defic Syndr 1992: 5: 904-914.
14. MacKay BJ, Pollock JJ, Iacono VJ, Baum BJ. Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. Infect Immun 1984: 44: 688-694.
15. Mandel ID, Barr CE, Turgeon E. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 1992: 21: 209-213
16. Marsh PD, Percival RS, Challacombe SJ. The influence of denture-wearing and age on the oral microflora. J Dent Res 1992: 71: 1374-1381.
17. Oppenheim FG, Xu T, McMillian FM et al. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 1988: 263: 7472-7477.
18. Oppenheim FG, Yang YC, Diamond RD, Hyslop D, Offner GD, Troxler RF The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J Biol Chem 1986: 261: 1177-1182.
19. Paquette DW, Waters GS, Stefanidou VL et al. Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins. J Clin Periodontol 1997: 24: 216-222.
20. Parvinen T. Stimulated salivary flow rate, pH, and lactobacillus and yeast concentrations in persons with different types of dentition. Scand J Dent Res 1984: 92: 412-418.
21. Pollock JJ, Denepitiya L, MacKay BJ, Iacono VJ. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun 1984: 44: 702-707.
22. Ramalingam K, Gururaja TL, Ramasubbu N, Levine MJ. Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity. Biochem Biophys Res Commun 1996: 225: 47-53.
23. Samaranayake LP, Lamey DJ. Oral candidosis. 1. Clinicopathologic aspects. Dent Update 1988: 15: 227-232.
24. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986: 15: 386-388.
25. Santarpia RP III, Cho MI, Pollock JJ. Parameters affecting the inhibition of Candida albicans GDH 2023 and GRI 2773 blastopore viability by purified synthetic salivary histidine-rich polypetides. Oral Microbiol Immunol 1990: 5: 226-232.
26. Santarpia RP III, Pollock JJ, Renner RP. Gwintnett AJ. In vivo antifungal efficacy of salivary histidine-rich polypeptides: preliminary findings in a denture stomatitis model system. J Prosthet Dent 1991: 66: 693-699.
27. Shannon IL, Prigmore JR, Chauncey HH. Modified Carlson-Crittenden device for the collection of parotid fluid. J Dent Res 1962: 41: 778-783.
28. Sugiyama K, Ogata K. High-performance liquid chromatographic determination of histidines in human saliva. J Chromatogr 1993: 619: 306-309.
29. Troxler RE Offner GD, Xu T, Vanderspek JC, Oppenheim FG. Structural renlationship between human salivary histatins. J Dent Res 1990: 69: 2-6.
30. Tsai H, Raj PA, Bobek LA. Candidacidal activity of recombinant human salivary histatin-5 and variants. Infect Immun 1996: 64: 5000-5007.
31. Xu L, Lal K, Pollock JJ. Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva. Oral Microbiol Immunol 1992: 7: 127-128.
32. Yeh C, Fox PC, Ship JA et al. Oral defense mechanisms are impaired early in HIV-1 infected patients. J Acquir Immune Defic Syndr 1988: 1: 361-366.